CYTK Cytokinetics, Incorporated
Healthcare$76.94-1.43%ClosedMarket Cap: $9.57B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$99.92
Target (Median)
$99.00
Target Range
$83.00 - $140.00
Upside from current price: 29.9%
Rating Distribution
7 Strong Buy12 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-07 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-06 | Stifel | maintain | Buy | Buy |
| 2026-05-06 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-06 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-05 | Needham | maintain | Buy | Buy |
| 2026-04-06 | Barclays | maintain | Overweight | Overweight |
| 2026-03-18 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-17 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.59 | $388.0M | 14 |
| Sun Dec 31 | $-1.76 | $876.0M | 14 |
| Mon Dec 31 | $0.84 | $1.52B | 8 |
| Tue Dec 31 | $4.20 | $2.31B | 12 |